Publications by authors named "Rodger D Macarthur"

Claim this Profile
T
The anti-retroviral therapy emtricitabine affects skeletal muscle DNA methylation and transcriptome patterns in a male HIV mouse model.
Alok Tripathi, Shabiha Sultana, Husam Bensreti, Jie Chen, Arindam Paul, Rodger D MacArthur

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Climate Change on Cellulitis: A Literature Review.
Ahmad A Rathor, Michelle Lin, Rodger D MacArthur

Cureus· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
Edgar T Overton, Isabelle R Weir, Markella V Zanni, Stephanie Fischinger, Rodger D MacArthur

J Acquir Immune Defic Syndr· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting Education at the Medical College of Georgia at Augusta University in Response to the COVID-19 Pandemic: the Pandemic Medicine Elective.
Joseph Antony Elengickal, Amanda M Delgado, Shefali Priya Jain, Elena Rae Diller, Catherine E Valli, Rodger D MacArthur

Med Sci Educ· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widely Disseminated Cryptococcosis Manifesting in a Previously Undiagnosed Human Immunodeficiency Virus (HIV)-Positive 18-Year-Old.
John Howard, Thomas Z Thompson, Rodger D MacArthur, Amyn M Rojiani, Joseph White

Am J Case Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical.
Matthew Zahn, Amesh A Adalja, Paul G Auwaerter, Paul J Edelson, Gail R Hansen, Rodger D MacArthur

Clin Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.
Álvaro H Borges, Andreas Lundh, Britta Tendal, John A Bartlett, Nathan Clumeck, Rodger D MacArthur

Clin Infect Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.
Rodger D Macarthur, Trevor N Hawkins, Stephen J Brown, Anthony Lamarca, Patrick G Clay

HIV Clin Trials· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.
Poorvi Chordia, Rodger D MacArthur

Expert Rev Gastroenterol Hepatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy.
Rodger D Macarthur

Am J Manag Care· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the XIX International AIDS Conference.
Rodger D Macarthur

Curr Infect Dis Rep· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.
Rodger D MacArthur, Herbert L DuPont

Clin Infect Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada.
Nisha Andany, Janet M Raboud, Sharon Walmsley, Christina Diong, Sean B Rourke, Rodger D Macarthur

HIV Clin Trials· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients.
Rodger D Macarthur

Curr Infect Dis Rep· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instantaneous inhibitory potential and inhibitory quotient show a modest association with virologic outcome: is either a useful surrogate for clinical drug efficacy?
Rodger D MacArthur

Clin Infect Dis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.
Thomas P Giordano, Glenn Bartsch, Yafeng Zhang, Ellen Tedaldi, Judith Absalon, Rodger D MacArthur

AIDS Patient Care STDS· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir/lamivudine combination in the treatment of HIV: a review.
Geetha Sivasubramanian, Emmanuel Frempong-Manso, Rodger D Macarthur

Ther Clin Risk Manag· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding HIV phenotypic resistance testing: usefulness in managing treatment-experienced patients.
Rodger D MacArthur

AIDS Rev· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of etravirine for the treatment of HIV infection.
Alice Tseng, Rodger D Macarthur

Ther Clin Risk Manag· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.
Edward M Gardner, Katherine H Hullsiek, Edward E Telzak, Shweta Sharma, Grace Peng, Rodger D MacArthur

AIDS· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.
Christine A Hughes, Linda Robinson, Alice Tseng, Rodger D MacArthur

Expert Opin Pharmacother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.
Mary van den Berg-Wolf, Katherine Huppler Hullsiek, Grace Peng, Michael J Kozal, Richard M Novak, Rodger D Macarthur

HIV Clin Trials· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
Birgitte B Simen, Jan Fredrik Simons, Katherine Huppler Hullsiek, Richard M Novak, Rodger D Macarthur

J Infect Dis· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
Jason V Baker, Grace Peng, Joshua Rapkin, David Krason, Cavan Reilly, Rodger D MacArthur

J Acquir Immune Defic Syndr· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents.
Rodger D MacArthur, Richard M Novak

Clin Infect Dis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis